Resultados de búsqueda - Manuel Hidalgo

Limitar resultados
  1. 1
    New insights into pancreatic cancer biology

    New insights into pancreatic cancer biology por Manuel Hidalgo

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy

    Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy por Manuel Hidalgo, S. Gail Eckhardt

    Publicado 2001
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer

    Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer por Antonio Jimeno, Manuel Hidalgo

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment

    Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment por Viktor Grünwald, Manuel Hidalgo

    Publicado 2003
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists

    New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists por Hetty E. Carraway, Manuel Hidalgo

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  6. 6
    Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotyping

    Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotyping por José Luís Royo, Manuel Hidalgo, Agustı́n Ruiz

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Matrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen

    Matrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen por Xiaoping Xu, Yao Wang, Zhihua Chen, Mark D. Sternlicht, Manuel Hidalgo, Bjorn Steffensen

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

    Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the He... por Denis Soulières, Neil Senzer, Everett E. Vokes, Manuel Hidalgo, Sanjiv S. Agarwala, Lillian L. Siu

    Publicado 2003
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer

    Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer por Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, Peter Atadja, Manuel Hidalgo, Anirban Maitra, Kapil N. Bhalla

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations

    A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations por Bárbara Angulo, Elena García-García, Rebeca Martínez, Ana Suárez‐Gauthier, Esther Conde, Manuel Hidalgo, Fernando López‐Ríos

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update

    Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update por Venkata Atluri, Manuel Hidalgo, Thangavel Samikkannu, Kesava Rao Venkata Kurapati, Rahul Dev Jayant, Vidya Sagar, Madhavan Nair

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  12. 12
    Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway

    Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway por Linda A. deGraffenried, Letitia C. Fulcher, William E. Friedrichs, Viktor Grünwald, Ratna B. Ray, Manuel Hidalgo

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    CYP3A Phenotyping Approach to Predict Systemic Exposure to EGFR Tyrosine Kinase Inhibitors

    CYP3A Phenotyping Approach to Predict Systemic Exposure to EGFR Tyrosine Kinase Inhibitors por Jing Li, Mats O. Karlsson, Julie R. Brahmer, Avery Spitz, Ming Zhao, Manuel Hidalgo, Sharyn D. Baker

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma

    Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma por Noriyuki Omura, Chung–Pin Li, Ang Li, Seung‐Mo Hong, Kimberly Walter, Antonio Jimeno, Manuel Hidalgo, Michael Goggins

    Publicado 2008
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

    Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms por Michele Cioffi, Sara Trabulo, Manuel Hidalgo, Eithne Costello, William Greenhalf, Mert Erkan, Jörg Kleeff, Bruno Sáinz, Christopher Heeschen

    Publicado 2015
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    A Combination of DR5 Agonistic Monoclonal Antibody with Gemcitabine Targets Pancreatic Cancer Stem Cells and Results in Long-term Disease Control in Human Pancreatic Cancer Model

    A Combination of DR5 Agonistic Monoclonal Antibody with Gemcitabine Targets Pancreatic Cancer Stem Cells and Results in Long-term Disease Control in Human Pancreatic Cancer Model por N.V. Rajeshkumar, Zeshaan A. Rasheed, Elena García-García, Fernando López‐Ríos, Kôsaku Fujiwara, William Matsui, Manuel Hidalgo

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding or Stable Disease after Induction Chemotherapy: A Trial of the Eastern Cooperative Oncology Group (E1500)

    A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding or Stable Disease after Induct... por Kishan J. Pandya, Suzanne E. Dahlberg, Manuel Hidalgo, Roger B. Cohen, Martin Lee, Joan H. Schiller, David H. Johnson

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Epidermal Growth Factor Receptor Dynamics Influences Response to Epidermal Growth Factor Receptor Targeted Agents

    Epidermal Growth Factor Receptor Dynamics Influences Response to Epidermal Growth Factor Receptor Targeted Agents por Antonio Jimeno, Belén Rubio‐Viqueira, María L. Amador, Darin Oppenheimer, Nadia Bouraoud, Peter Kulesza, Valeria Sebastiani, Anirban Maitra, Manuel Hidalgo

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients

    Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients por Jing Li, George Cusatis, Julie R. Brahmer, Alex Sparreboom, Robert W. Robey, Susan E. Bates, Manuel Hidalgo, Sharyn D. Baker

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells

    Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells por Enza Lonardo, Michele Cioffi, Patricia Sancho, Yolanda Sanchez-Ripoll, Sara Trabulo, Jorge Navarro‐Dorado, Anamaria Balic, Manuel Hidalgo, Christopher Heeschen

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: